Andrew Cheng, MD, PhD

Chief Medical Officer, Executive Vice President

Dr. Cheng joined Gilead Sciences in 1999 and was appointed to the role of Chief Medical Officer in April 2018. In this role, he is responsible for leading the company’s Medical Affairs organization, as well as overseeing clinical development for the company’s programs in HIV/AIDS. Dr. Cheng is board certified in internal medicine and trained at the University of California, Los Angeles.

Dr. Cheng is a member of the board of the Global Virus Network, based in Baltimore, Maryland. He received his bachelor’s degree from the Johns Hopkins University and his medical degree and PhD in Cellular and Molecular Biology from Columbia University College of Physicians and Surgeons.